Cytokine release syndrome (CRS) is the result of massive pro-inflammatory cytokine release
and imbalance in the absence of adequate immunomodulation from signals such as …

The clinical spectrum of COVID-19 ranges from asymptomatic disease to viral pneumonia
leading to acute respiratory distress syndrome (ARDS), multiorgan failure, and death. In …

COVID-19, the syndrome caused by the infection with SARS-CoV-2 coronavirus, is
characterized, in its severe form, by interstitial diffuse pneumonitis and acute respiratory …

During the COVID-19 pandemic, research on" cytokine storms" has been reinvigorated in
the field of infectious disease, but it also has particular relevance to cancer research …

The novel coronavirus respiratory illness (COVID-19) is a public health emergency of global
concern. Patients with cancer are at high risk of infections, due to an overall …

Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

The high fatality rate of COVID-19 pneumonia, especially in imuno-compromised high risk
patient populations, like those with hematologic malignancies or solid tumors who are …

Background: The clinical presentation of coronavirus disease 19 (COVID-19) is the result of
intricate interactions between the novel coronavirus (SARS-CoV-2) and the immune system …

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a
worldwide sanitary emergency. The viral biology is only partially known, with some aspects …

Background: The clinical presentation of coronavirus disease 19 (COVID-19) is the result of
intricate interactions between the novel coronavirus and the immune system. In patients with …